Opendata, web and dolomites

GET-UP BAT

GPCR Exploitation To Unlock the Power of Brown/Beige Adipose Tissue

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GET-UP BAT project word cloud

Explore the words cloud of the GET-UP BAT project. It provides you a very rough idea of what is the project "GET-UP BAT" about.

gcprs    observing    cells    sensitivity    uncovering    hundreds    consumption    economic    vivo    hindered    head    unfortunately    people    life    benefit    administration    treating    lowered    commercial    metabolic    holds    starting    poc    obese    combination    adipose    suffer    analogues    protein    expectancy    adverse    adrenergic    activation    worldwide    seek    tissue    beta    obesity    position    treatment    functions    burning    bat    ipr    scope    diseases    beige    vitro    longer    options    experts    platforms    alternatives    team    treat    pharmacology    acrobat    brown    disease    critical    insulin    compounds    enormous    grant    receptors    consuming    oxygen    ip    strengthen    assembled    bodyweight    coupled    validated    poised    therapeutic    performed    quality    patentable    extend    ligand    calorie    ideally    diabetes    millions    maximize    found    lived    combined    discovery    class    mice    strategy    erc    innovation    strategies    attempts    linked    desperately    initial    glucose    gpcr    largely    peptide    harness    screen    diminish    societal    consequently    tangible    cardiovascular   

Project "GET-UP BAT" data sheet

The following table provides information about the project.

Coordinator
KOBENHAVNS UNIVERSITET 

Organization address
address: NORREGADE 10
city: KOBENHAVN
postcode: 1165
website: www.ku.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 149˙986 €
 EC max contribution 149˙986 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) coordinator 149˙986.00

Map

 Project objective

Hundreds of millions of people suffer from obesity and diabetes worldwide. These diseases diminish both life quality and expectancy and new treatment strategies are desperately needed. One possible approach is to target the calorie-burning and glucose-consuming functions of brown and beige adipose tissue (B/BAT). Previous attempts to harness the therapeutic potential of B/BAT have largely focused on the β-adrenergic class of G protein-coupled receptors (GCPRs). Unfortunately, these methods are hindered by adverse cardiovascular side effects linked to adrenergic activation. Therefore, uncovering non-adrenergic alternatives to exploit B/BAT for treating metabolic disease holds the potential for enormous societal and economic benefit.

Here, we propose the activation of one such non-adrenergic GPCR on B/BAT as a means to treat obesity and diabetes. We identified this GPCR from a screen of B/BAT receptors performed in my ERC Starting Grant project, aCROBAT. We found that treating brown adipose cells with the peptide ligand for this GPCR increased oxygen consumption. We recognized the therapeutic potential after observing that ligand administration in vivo lowered bodyweight and improved insulin sensitivity in obese mice. However, the resources required to develop this discovery into a tangible innovation extend beyond the scope of aCROBAT.

Consequently, I’m applying for an ERC PoC grant for critical support to take the initial steps to commercial application. Specifically, we seek to strengthen our IP position by developing patentable, longer-lived analogues of the ligand. Importantly, we will test these lead compounds head-to-head and in combination with current treatment options. We have assembled a team of experts to address key aspects from peptide design and pharmacology to IPR strategy and commercial development. Combined with our validated in vitro and in vivo testing platforms, we are ideally poised to maximize innovation potential.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GET-UP BAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GET-UP BAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More  

IMMUNOTHROMBOSIS (2019)

Cross-talk between platelets and immunity - implications for host homeostasis and defense

Read More  

RODRESET (2019)

Development of novel optogenetic approaches for improving vision in macular degeneration

Read More